Jones Day Reps P&G in Joint Venture With Teva
Financial details of the transaction were not disclosed, but the companies said the partnership would combine their existing over-the-counter drug businesses in all markets outside of North America. Those markets generated sales of more than $1 billion in 2010, the firms said.
The deal is expected to close in the fall, pending regulatory approvals.
Under the agreement, Jerusalem-based Teva...
To view the full article, register now.